Evidence map›Paper›PMID 39035931›Full record

ReviewACS omega2024

Polysaccharide Hydroxyapatite (Nano)composites and Their Biomedical Applications: An Overview of Recent Years.

Wanderson Barros Costa, Ana F Félix Farias, Edson Cavalcanti Silva-Filho, Josy A Osajima, Santiago Medina-Carrasco, Maria Del Mar Orta, Maria G Fonseca

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. [Research progress in repair and reconstruction of tumor-related bone defects in proximal femur].Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wanderson Barros CostaFuel and Materials Laboratory - NPE-LACOM, UFPB, 58051-085, João Pessoa, Paraiba, Brazil.ORCID https://orcid.org/0000-0002-7051-8492
Ana F Félix FariasFuel and Materials Laboratory - NPE-LACOM, UFPB, 58051-085, João Pessoa, Paraiba, Brazil.
Edson Cavalcanti Silva-FilhoInterdisciplinary Laboratory for Advanced Materials - LIMAV, UFPI, 64049-550, Teresina, Piaui, Brazil.
Josy A OsajimaInterdisciplinary Laboratory for Advanced Materials - LIMAV, UFPI, 64049-550, Teresina, Piaui, Brazil.
Santiago Medina-CarrascoSGI Laboratorio de Rayos X - Centro de Investigación, Tecnología e Innovación de la Universidad de Sevilla (CITIUS), 41012, Sevilla, Spain.ORCID https://orcid.org/0000-0003-1353-9331
Maria Del Mar OrtaDepartamento de Química Analítica, Facultad de Farmacia, Universidad de Sevilla, C/Profesor García, González 2, 41012 Sevilla, Spain.
Maria G FonsecaFuel and Materials Laboratory - NPE-LACOM, UFPB, 58051-085, João Pessoa, Paraiba, Brazil.ORCID https://orcid.org/0000-0002-7818-4917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydroxyapatite can combine with polysaccharide originating biomaterials with special applications in the biomedical field. In this review, the synthesis of (nano)composites is discussed, focusing on natural polysaccharides such as alginate, chitosan, and pectin. In this way, advances in recent years in the development of preparing materials are revised and discussed. Therefore, an overview of the recent synthesis and applications of polyssacharides@hydroxyapatites is presented. Several studies based on chitosan@hydroxyapatite combined with other inorganic matrices are highlighted, while pectin@hydroxyapatite is present in a smaller number of reports. Biomedical applications as drug carriers, adsorbents, and bone implants are discussed, combining their dependence with the nature of interactions on the molecular scale and the type of polysaccharides used, which is a relevant aspect to be explored.

Identifiers

PMID39035931
PMCPMC11256335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.